SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is drawing heavy community interest as investors weigh its pivot to front-line AML treatment against the ongoing REGAL Phase 3 trial, which remains a key focus for potential trial halts or buyout speculation. While some investors argue that the stock is currently overhyped and risky due to a narrow margin for error in clinical results, many remain heavily invested, debating the timing of trial events and the broader implications of a successful drug rollout.

Dogelon Mars

Dogelon Mars is trending as community members weigh its potential as an OG meme coin against frustrations over prolonged stagnation and lackluster price performance. While some loyalists remain optimistic, citing long-term holding strategies and historical associations with Elon Musk, others are actively debating its status as a high-risk, speculative asset in a crowded meme coin market.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

RETIRE is trending as investors rally around the concept of a tokenized retirement fund, with the community actively promoting weekly dollar-cost averaging to build long-term wealth. Proponents emphasize the project as a decentralized alternative to traditional retirement plans, viewing the current price action as a key accumulation phase for potential future growth.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens is trending as investors debate the impact of institutional integration and stablecoin adoption on its long-term utility, while community members weigh the potential for a breakout against ongoing market volatility. Sentiment remains polarized, with some focusing on positive development milestones and partnerships, while others express frustration over stagnant price action and technical headwinds.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as community discussion intensifies around a pending U.S. Supreme Court decision on patent infringement litigation and the potential impact of "skinny label" generic competition on its market share. Investors are simultaneously focusing on the company's progress toward achieving positive cash flow and long-term value, as speculation persists regarding a potential acquisition by larger pharmaceutical firms following recent operational restructuring.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is seeing a surge in investor interest and volume following the announcement that it has selected Siemens Energy to supply equipment for a major data center power project tied to Applied Digital. Community sentiment is largely focused on the potential for this partnership to validate the company's role in the rapidly growing AI power infrastructure sector, as investors weigh the stock's recent volatility against the promise of long-term contract conversions.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently facing significant selling pressure as investors express frustration over foundation governance and concerns regarding supply inflation. While some in the community continue to accumulate on price dips, others are rotating capital into competing ecosystems due to stagnant network growth and the ongoing downtrend.

Endeavour Silver Corp. is a mineral company, which engages in the evaluation, acquisition, development and exploitation of precious metal properties in Mexico and Chile. The firm's projects include the Terronera property in Jalisco, the El Compas property, the Guanacevi Mine in Durango, Bolanitos Mines in Guanajuato, and the Parral project in Chihuahua, Mexico. The company was founded by Bradford James Cooke on March 11, 1981 and is headquartered in Vancouver, Canada.

Endeavour Silver Corp.

Endeavour Silver is trending as the community scrutinizes recent production reports and earnings while expressing frustration over the stock's perceived underperformance compared to the rapid climb in silver prices. Investors are closely debating the impact of ongoing hedging strategies and management performance, while many continue to accumulate shares, betting that the company's long-term production growth and silver's sustained bull market will eventually drive significant upside.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is trending due to rising geopolitical tensions and uncertainty surrounding U.S. trade policies, which has led the trading community to focus on volatility-hedging strategies. Traders are actively debating the sustainability of the ETF's price action, with many discussing its propensity for decay while others use it as a tactical tool to bet on sudden market reactions to potential conflict escalation.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials remains a focal point for the critical minerals sector as investors weigh long-term growth from domestic magnet production against short-term volatility driven by geopolitical tensions and trade policy. The community is heavily focused on government-backed catalysts, processing infrastructure progress, and the potential for a favorable supply environment as the industry continues to scale toward energy and defense independence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK plc (LON:GSK) Receives Consensus Recommendation of "Hold" from Analysts

GSK plc (LON:GSK - Get Free Report) has been assigned an average recommendation of "Hold" from the seven analysts that are covering the firm, Marketbeat reports. One research analyst has rated the...

Two major drug companies are the latest to join TrumpRx

Exclusive: The White House is expecting to announce an expansion of the drugmakers offering discounts on TrumpRx.gov, FOX Business has learned.As early as today, Amgen and GSK will be added to the...

GSKs RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 1849 Years at Increased Risk

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults...

AnaptysBio Details First Tracks Bio Spin-Off, Jemperli Royalty Surge and GSK Litigation Timeline

AnaptysBio (NASDAQ:ANAB) CEO Daniel Faga outlined progress on the company's planned separation into two entities, provided an update on its royalty streams and ongoing litigation related to GSK's...

Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production

Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production PR...

FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder

FDA approves expanded use of Wellcovorin tablets to treat cerebral folate deficiency linked to the FOLR1 gene in adults and children.read more...

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma

GSK licenses linerixibat to Alfasigma for cholestatic pruritus in PBC, securing $300M upfront and potential milestone payments as the drug awaits FDA review.

JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer

J&J gains EU approval to expand Akeega use to treat patients with BRCA-mutated metastatic hormone-sensitive prostate cancer.

Top Stock Reports for Visa, Chevron & Toyota Motor

Visa beats fiscal Q1 estimates as revenue jumps 15% and cross-border volumes rise 12%, but higher client incentives, expenses and regulatory risks cloud margins.

GSK: Alfasigma To Acquire Rights To Develop, Manufacture, Commercialise Linerixibat

(RTTNews) - GSK plc (GSK, GSK.L) and Alfasigma announced a licence agreement under which Alfasigma will acquire worldwide exclusive rights to develop, manufacture and commercialise linerixibat, an...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSK
Glaxosmithkline plc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GSK News

GSKGlaxosmithkline plc - ADR